terbutaline, Brethine, Bricanyl, and Brethaire are no longer available in the U.S. (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

The recommended subcutaneous (under skin) dose is 0.25 mg every 15-30 minutes for two doses. The maximum dose is 0.5 mg within 4 hours.

The recommended dose for the inhaler is 2 puffs every 4 to 6 hours.

The dose for preterm labor is 2.5 to 10 mcg/min by intravenous infusion initially, then increase amounts every 10 to 20 minutes. The typical effective dose is 17.5 to 30 mcg/min. Treatment should not exceed 72 hours.

DRUG INTERACTIONS: Combining terbutaline with thioridazine (Mellaril) may increase the occurrence of abnormal heart rhythms because both drugs can cause abnormal heart rhythms. The effects of terbutaline (a beta stimulant) are reversed by beta-blockers, for example, atenolol (Tenormin), nadolol (Corgard), propranolol (Inderal), and metoprolol (Lopressor). Conversely, terbutaline may reduce the effect of beta-blockers. Therefore, terbutaline and beta-blockers should not be used together.

PREGNANCY: Terbutaline reduces uterine contractions and may inhibit labor. There are no adequate studies of terbutaline in pregnant women.

NURSING MOTHERS: Terbutaline is found in small amounts in the breast milk of nursing women. The American Academy of Pediatrics considers terbutaline to be compatible with breastfeeding.

Medically reviewed by Eni Williams, PharmD

Reference: FDA Prescribing Information

Medically Reviewed by a Doctor on 3/30/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index